A detailed history of Gibson Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Gibson Capital, LLC holds 3,280 shares of MRK stock, worth $333,313. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,280
Previous 3,280 -0.0%
Holding current value
$333,313
Previous $406,000 8.37%
% of portfolio
0.08%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$123.8 - $132.96 $6,190 - $6,648
50 Added 1.55%
3,280 $406,000
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $3,305 - $3,597
33 Added 1.03%
3,230 $352,000
Q2 2023

Jul 17, 2023

BUY
$108.61 - $118.38 $1,954 - $2,130
18 Added 0.57%
3,197 $368,000
Q3 2022

Oct 14, 2022

SELL
$84.53 - $94.96 $22,062 - $24,784
-261 Reduced 7.59%
3,179 $275,000
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $287,205 - $325,561
3,440 New
3,440 $310,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $257B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Gibson Capital, LLC Portfolio

Follow Gibson Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gibson Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gibson Capital, LLC with notifications on news.